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Abstract
Neurotrophin-3 (NT-3) is one of the most potent stimulators for survival of auditory sensory neurons. Viral transfer of
neurotrophins into auditory neurons may offer a route to provide a permanent supply of the growth factor and guarantee
their long-term survival. Herpes simplex virus type 1 (HSV-1)-based vectors have demonstrated their effectiveness to
transfer genes into peripheral sensory neurons. In the present report, we have produced a HSV-1-based amplicon vector
expressing NT-3. This vector efficiently infects isolated auditory neurons and stimulates their survival during distinct
developmental stages of the inner ear. Therefore, this vector may present a unique entry point to develop therapies
preventing or treating hearing impairment caused by the degeneration of auditory neurons. q 2001 Published by Else-
vier Science Ireland Ltd.
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Members of the neurotrophin gene family have been
shown to be essential for survival of inner ear sensory
neurons and maintenance of innervation with their target
sensory epithelia [5]. Both brain-derived neurotrophic
factor (BDNF) and neurotrophin-3 (NT-3) are expressed
in the inner ear sensory epithelia of avians and mammals
during development [11,12,18]. Simultaneously, their high-
affinity receptors TrkB and TrkC, respectively, are
expressed in the peripheral auditory sensory neurons,
which connect the sensory epithelia with their correspond-
ing central auditory nuclei [10–12]. The survival of auditory
sensory neurons isolated during development or adulthood
is stimulated by exposure to BDNF or NT-3 [1,7,10,11,15].
The essential character of these neurotrophins for auditory
neuron survival in vivo has been confirmed in mice lacking
these factors or the corresponding Trk receptors. Mice lack-
ing NT-3 lose more than 80% of their cochlear neurons,
which fail to maintain innervation with their target organs
[5].
Damage to the inner ear may be caused by aging, injury,
ototoxic drugs, acoustic trauma or genetic diseases [6]. The
majority of hearing loss is caused by damage or loss of
sensory hair cells or auditory neurons. Cochlear implants
may substitute hair cell function by electrical stimulation
of auditory neurons. However, survival of a critical number
of neurons is required for proper function of the prosthesis.
To maintain survival of auditory neurons inside the
damaged inner ear, BDNF and NT-3 have been introduced
via osmotic pumps [3,4,13,16]. Alternatively, viruses may
offer a strategy to provide long-term expression of neuro-
trophins inside auditory neurons and maintain their function
[6]. In this context, defective Herpes simplex virus type 1
(HSV-1) vectors offer some characteristics which make
them the ideal gene transfer vector for the peripheral
nervous system [14]. Most importantly, HSV-1 infects
neurons very efficiently and acquires a state of latency with-
out compromising normal cellular functions.
In the present study, we have developed a HSV-1-based
amplicon vector containing the NT-3 gene. Gene transfer
with this vector led to the efficient expression of NT-3 in
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fibroblasts. Biological activity of NT-3 was confirmed by
infection of isolated avian auditory sensory neurons, which
are known to respond to this growth factor [1,10,11]. By
analyzing distinct developmental timepoints, we observed
stimulation of survival of these neurons comparable with
exogenously added NT-3. This vector may now be used to
express this neurotrophin in auditory neurons in vivo and
thus offer a potential tool to prevent neurodegenerative
processes inside the damaged inner ear.
NT-3 has been shown to act as one of the main regulators
of cochlear neuron survival in vertebrates [1,5,10]. We first
examined the effects of recombinant NT-3 on the survival of
isolated avian auditory sensory neurons. Embryonic heads
were cut at the midsagittal level and after removal of brain
tissue the membranous labyrinth and the cochlear duct were
isolated. Ganglia were separated and neuronal cell cultures
were prepared as described in detail earlier [7]. Briefly,
ganglia were dissociated after treatment with 0.05% trypsin
using a fire-polished Pasteur pipette. Cells were plated at a
final density of 1000–2000 cells in 0.5 ml per well. After 2
h, the serum concentration was reduced to 1% and recom-
binant NT-3 or viruses were added. After addition of differ-
ent concentrations of recombinant NT-3, cultures were
grown for 2 days and then processed for immunocytochem-
ical staining with a neuron-specific tubulin as described in
detail earlier [7]. Briefly, after fixation in 4% paraformalde-
hyde and inhibition of endogenous peroxidase, cells were
blocked with 20% goat serum and incubated with the class
III b-tubulin (TuJ1) antibody (Babco; diluted 1:500) over-
night. Cultures were washed and incubated with biotiny-
lated IgG antibodies (diluted 1:200), for 45 min at room
temperature. Finally, cells were washed and immunoreac-
tivity was detected using the avidin–biotin peroxidase
complex method (Vectastain Kit, Vector Laboratories).
TuJ1-positive neurons with neurites four times longer than
cell bodies were scored as surviving neurons. This number
was expressed as the percentage of the total number of
neurons plated. Statistics were performed using the
Student’s t-test. Compared with control cultures, we
observed a significant increase of neuronal survival, with
more than 50% of the neurons surviving at 1 and 5 ng/ml
of NT-3 (Fig. 1A).
Having confirmed the neurotrophic potential of NT-3 on
auditory sensory neurons, we were interested to transfer this
growth factor directly into auditory sensory neurons. To
introduce NT-3 into neurons, we used a defective HSV-1
vector or amplicon, that has been shown to permit efficient
transfer of neurotrophins into auditory neurons [7,8]. For
construction of pHSVnt-3 (Fig. 1B), a fragment containing
the cDNA encoding for rat NT-3 was inserted into the vector
pHSVpUC, and packaging and amplification of this vector
were performed using standard procedures [9]. Expression
of NT-3 was confirmed by an enzyme-linked immunosor-
bent assay (ELISA) kit (Promega) after infection of
HEK293 cells. Briefly, quantification of NT-3 was deter-
mined in 96-well microplates coated with a monoclonal
anti-human NT-3 antibody which cross-reacts with rat
NT-3. Two hundred microliters of the NT-3 standard and
the supernatants from pHSVlacZ [9] expressing the Escher-
ichia coli lacZ marker gene and pHSVnt-3-infected cells
were added to each well, and the plates were incubated
for 6 h at room temperature. After washing, 100 ml of mono-
clonal anti-NT3 antibody, followed by 100 ml of anti-mouse
IgG peroxidase conjugate were added to each well and incu-
bated for 2.5 h. After washing, enzymatic activity was
detected by adding the substrate solution for 15 min. Absor-
bance values were measured at 450 nm using an ELISA
reader (Dynatech MR5000). Supernatants from cultures
infected with 1.3 £ 103 infectious vector units (ivu) of
pHSVnt-3 contained an average of 278 pg/ml of NT-3,
whereas no significant amounts were obtained from cells
transduced with up to 3.1 £ 104 ivu of pHSVlacZ.
To verify biological activity of NT-3, we infected isolated
avian auditory sensory neurons which have been shown to
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Fig. 1. Stimulation of auditory neurons by recombinant NT-3 and
structure of the amplicon vector. (A) Survival of chicken auditory
neurons isolated at embryonic day 8 upon addition of different
amounts of recombinant NT-3. (B) Structure of the pHSVnt-3
amplicon consisting of the transcription unit composed of the
IE 4/5 promoter, the rat nt-3 cDNA; the HSV-1 origin of replication
(oris) and the HSV-1 packaging site (‘a’); and sequences required
for propagation in E. coli (ori and Amp).
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respond to this growth factor during distinct stages of avian
development [1]. We transduced cochlear neurons cultures
isolated between embryonic days 5.5 (E5.5) and E14 with
1.65–104 ivu/ml of pHSVnt-3 (multiplicity of infection
(MOI): 8) and 3.1 £ 104 ivu/ml of pHSVlacZ (MOI: 15),
respectively, and examined the effects after 2 days. HSV-
1-mediated transfer of NT-3 resulted in an increased survi-
val response of cochlear neurons isolated between E5.5 and
E9, compared with cultures infected with a prototype ampli-
con vector pHSVlacZ or uninfected cultures (Figs. 2A,B
and 3). Compared with neurons grown in the presence of
exogenously added NT-3, a similar amount of neurons
survived in cultures transduced with pHSVnt-3 at these
stages. Neuronal cultures prepared from E14 of develop-
ment showed no increased survival response to pHSVnt-3
(Figs. 2C,D and 3). Similarly, exogenously added recombi-
nant NT-3 had previously been demonstrated to have no
stimulatory effect at E11 and E13 [1].
The present report underlines the neurotrophic role of NT-
3 during innervation of the chicken cochlea. Cochlear
neurons respond to NT-3 between E5 and E9 in vitro when
peripheral fibers of the cochlear ganglion invade the sensory
epithelium and start early synaptogenesis in vivo. After E9,
no increased survival of auditory neurons was observed upon
stimulation by NT-3. These observations agree with the
expression of NT-3 in vivo, which has been detected at E6
and E8, but not at E12 [11]. However, stimulation of auditory
neurons is also observed at E5 [1], when no expression of NT-
3 has been detected [11]. The most likely explanation for this
discrepancy is the presence of high-affinity receptors for NT-
3, encoded by TrkC, which are expressed during these stages
[2]. TrkC expression thus precedes the expression of NT-3 in
vivo. Additionally, TrkC is also maintained during later
embryogenesis and the post-hatch period, when NT-3 is
possibly supplied by central sources [2]. In summary and
as suggested earlier, NT-3 appears to play only a transitory
role during chicken development [2,11]. This situation is
strikingly different in mammals, where NT-3 is expressed
throughout development and is the only neurotrophin present
at adult stages [18,19]. In the adult cochlea, NT-3 is
expressed in inner hair cells, which are innervated by type I
sensory neurons which comprise the vast majority of
cochlear neurons in mice. The importance of this neurotro-
phin during development is convincingly demonstrated by
the loss of more than 80% of cochlear sensory neurons in
mice lacking NT-3 [5]. In contrast and as expected, lack of
signaling via other neurotrophin members only produces
minor or no defects to auditory system development [5].
NT-3 thus may be considered the most promising candidate
to provide neurotrophic support for mammalian auditory
sensory neurons, which are at risk of undergoing neurode-
generative processes. Indeed, in vitro models for neurode-
generation provided evidence that NT-3 is the most efficient
neurotrophin for survival of maturing auditory neurons [15].
Moreover, neuronal degeneration caused by ototoxins was
largely prevented by NT-3 in vitro, although BDNF and NT-
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Fig. 2. Images of cochlear neuron cultures isolated at day 8 (A,B)
or day 14 (C,D) of chicken development which have been trans-
duced with pHSVlacZ (A,C) or pHSVnt-3 (B,D). After 48 h in
culture, cells were fixed and stained with a tubulin antibody to
visualize neurons. Cultures prepared at embryonic day 8 and
infected with pHSVnt-3 show increased neuronal survival
compared with control cultures infected with pHSVlacZ. At day
14 of development, similar amounts of neurons are observed in
both pHSVlacZ- and pHSVnt-3-transduced cultures. Neuronal
cultures were infected with 1.65 £ 104 ivu/ml of pHSVnt-3 and
3.1 £ 104 ivu/ml of pHSVlacZ, respectively. Arrows point out
neurons stained with the tubulin antibody. Scale bar, 100 mm.
Fig. 3. Temporal pattern of neurotrophic effects of virally trans-
ferred NT-3 on chicken auditory neurons. Bar charts show the
survival of mock-, pHSVlacZ- and pHSVnt-3-infected neurons
isolated at the embryonic day of development (E) indicated,
after 48 h. The results are expressed as the means ^ SD of
three separate determinations for each experimental condition.
The data shown demonstrate a clear survival-promoting effect of
pHSVnt-3 between E5.5 and E9, whereas neurons do not
respond at E14. Values from cultures infected with pHSVnt-3
are statistically different from values for pHSVlacZ and the unin-
fected control (P , 0:001, t-test) at E5.5–E9.
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4 were shown to act with similar efficacy [20]. Most impor-
tantly, upon infusion via osmotic pumps, NT-3 has consis-
tently protected cochlear neurons from noise- and
aminoglycoside-induced ototoxicity [3,4,13,16]. In this
context, NT-3 has additionally been shown to participate in
the protection of hair cells [3]. BDNF has also been reported
to prevent loss of auditory neurons in vivo, although with less
efficiency than NT-3 [16]. The fact that NT-3 may provide a
potent protection of auditory sensory neurons in vivo
prompted us to develop a viral vector expressing this neuro-
trophin. Previous studies have described HSV-1-based
amplicon vectors with similar characteristics expressing
BDNF, which were shown to stimulate neuronal survival
and prevent degeneration of auditory neurons [7,8,17].
Compared with other viral vectors, like for instance adeno-
virus, HSV-1-based vectors are unique in their capacity to
infect neurons very efficiently and harbor the potential to
provide a life-long supply of the gene product expressed by
the vector, thereby creating an endogenous source and elim-
inating the need to use osmotic pumps. Our results demon-
strate the HSV-1-mediated expression of biologically active
NT-3 in auditory sensory neurons, which efficiently stimu-
lates their survival in vitro. Future experiments will now be
directed to explore the neuroprotective capacity of this vector
in the inner ear and other NT-3-dependent peripheral sensory
systems in vivo.
The results of this study highlight the unique importance
of NT-3 for the formation of the peripheral nervous system
innervating the inner ear and the survival of auditory
sensory neurons. The efficient transfer of this neurotrophin
into these neurons via a HSV-1-based amplicon vector
underlines the capacity of this system to permanently supply
the inner ear with neurotrophic molecules. The future appli-
cation of this vector will include the introduction of NT-3
into auditory sensory neurons in vivo which may offer a
decisive key step to prevent their degeneration and thus to
ameliorate or avoid hearing impairment.
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